
    
      This is an observational, perspective trial on patients affected by gastrointestinal cancer
      (any site of disease along with gastrointestinal tract) who have been prescribed FOLFIRI in
      standard clinical practice. All patients will be treated and monitored according to the local
      clinical practice. No additional procedures/patient visits in comparison with the usual
      clinical practice are planned for the study.
    
  